Key result
PCOS is linked to greater abdominal adiposity and ~75% higher fasting insulin versus controls.
Why the study?
Do patients with polycystic ovary syndrome exhibit differences in body fat distribution, insulin sensitivity, and lipoprotein profiles compared to age- and weight-matched controls?
Case-Control (n=30)
Do patients with polycystic ovary syndrome exhibit differences in body fat distribution, insulin sensitivity, and lipoprotein profiles compared to age- and weight-matched controls?
Answers are grounded in this paper and cite their sources.
PCOS patients exhibit significant metabolic abnormalities, including abdominal adiposity, hyperinsulinemia, and reduced insulin sensitivity, independent of body mass index.
Polycystic ovary syndrome (PCOS) is characterized by various endocrine and metabolic abnormalities, whose mutual associations and symptoms are still not clear. In the present study, fifteen PCOS patients and fifteen controls, matched for age and body weight, were investigated. Endocrine profiles were evaluated by the nafarelin and the adrenocorticotropin (ACTH) test. Insulin sensitivity was determined by an intravenous insulin tolerance test. Patients showed a significant predominance of abdominal adiposity [waist-to-hip ratio (WHR), 0.86 +/- 0.05 vs. 0.79 +/- 0.04] with markedly higher fasting insulin levels (+75%) and reduced insulin sensitivity (-37%). Fasting insulin, testosterone and free androgen index were positively correlated with the body mass index (BMI). In contrast, insulin sensitivity and BMI were inversely correlated in patients only. In the nafarelin test increases of 17-OH-progesterone and androstenedione were higher in patients and positively correlated with fasting insulin levels. Lipoprotein profiles showed trends towards higher triglycerides, lower HDL-cholesterol and a preponderance of small, dense LDL in patients. In PCOS higher triglycerides and lower HDL cholesterol were correlated with insulin sensitivity. It is concluded that PCOS patients show metabolic abnormalities combined with a more adroid type of adiposity when compared to cyclic controls of similar BMI.
No takes yet. Share an insight, caveat, or question.
Strowitzki et al. (2002) conducted a case-control in Polycystic ovary syndrome (n=30). Polycystic ovary syndrome vs. Cyclic controls was evaluated on Waist-to-hip ratio (WHR). Polycystic ovary syndrome was associated with greater abdominal adiposity, higher fasting insulin, and reduced insulin sensitivity compared to controls.
Synapse has enriched 10 related papers. Consider them for comparative context: